Skip to content

Latest

Reckitt Benckiser discontinues Suboxone Tablets

Reckitt Benckiser Pharmaceuticals Inc. has issued a Citizen Petition with the Food and Drug Administration requesting action to curtail the risk of pediatric exposure with buprenorphine-containing products for the treatment of opioid dependence.

Dream Water to be featured on CNBC show

David Lekach and Vincent Porpiglia, the founders of Dream Water, are slated to be featured on CNBC’s "How I Made My Millions." The sleep aid beverage maker said Lekach and Porpiglia are scheduled to appear on the program on Monday, Sept. 24, at 9:00 pm ET. Dream Water will be highlighted in

Mylan generics ships generics of Diovan, Antivert

Mylan Inc. has released generic versions of Novartis’ Diovan HCT tablets and Pfizer’s Antivert tablets. Mylan said Friday that its Diovan generic, valsartan and hydrochlorothiazide tablets, come in strengths of 80/12.5 mg, 160/12.5 mg, 160/25 mg, 320/12.5 mg and 320/25 mg.

CVS helps Medicine Abuse Project get message out

As part of its sponsorship of The Partnership at Drugfree.org’s The Medicine Abuse Project, CVS Caremark Corp. will ask millions of its customers to take the project’s pledge to learn about teen medicine abuse, safeguard medicines in the home and talk to teens about drug misuse and abuse.

Boom projected for retail health clinic market

Boom projected for retail health clinic market

A continuing shortage of primary care doctors and overburdened emergency rooms are pushing a rising number of consumers to retail health clinics and urgent care centers, according to a study by Marketdata Enterprises Inc.

McKesson names U.S. Pharmaceutical president

McKesson names U.S. Pharmaceutical president

McKesson Corp. has appointed Mark Walchirk, a top executive in its specialty drug unit, as president of McKesson U.S. Pharmaceutical, the company’s largest business. The pharmaceutical distributor said Monday that Walchirk takes over as U.S.

Merlo keeps CVS Caremark on right track

CVS Caremark Corp. is poised for a strong finish to 2012, and its pharmacy business is looking forward to generics growth in 2013 and 2014, president and chief executive officer Larry Merlo said at the Morgan Stanley Healthcare Conference this month.